110 related articles for article (PubMed ID: 18194395)
1. Validation of a four-graded scale for severity of heartburn in patients with symptoms of gastroesophageal reflux disease.
Junghard O; Wiklund I
Value Health; 2008; 11(4):765-70. PubMed ID: 18194395
[TBL] [Abstract][Full Text] [Related]
2. Assessing symptoms in gastroesophageal reflux disease: how well do clinicians' assessments agree with those of their patients?
McColl E; Junghard O; Wiklund I; Revicki DA
Am J Gastroenterol; 2005 Jan; 100(1):11-8. PubMed ID: 15654774
[TBL] [Abstract][Full Text] [Related]
3. Validation of a symptom diary for patients with gastro-oesophageal reflux disease.
Puhan MA; Guyatt GH; Armstrong D; Wiklund I; Fallone CA; Heels-Ansdell D; Degl'Innocenti A; Veldhuyzen van Zanten SJ; Tanser L; Barkun AN; Chiba N; Austin P; El-Dika S; Schünemann HJ
Aliment Pharmacol Ther; 2006 Feb; 23(4):531-41. PubMed ID: 16441474
[TBL] [Abstract][Full Text] [Related]
4. Effect of baseline symptom severity on patient-reported outcomes in gastroesophageal reflux disease.
Junghard O; Wiklund IK
Eur J Gastroenterol Hepatol; 2007 Jul; 19(7):555-60. PubMed ID: 17556901
[TBL] [Abstract][Full Text] [Related]
5. Esomeprazole (40 mg) compared with lansoprazole (30 mg) in the treatment of erosive esophagitis.
Castell DO; Kahrilas PJ; Richter JE; Vakil NB; Johnson DA; Zuckerman S; Skammer W; Levine JG
Am J Gastroenterol; 2002 Mar; 97(3):575-83. PubMed ID: 11922549
[TBL] [Abstract][Full Text] [Related]
6. Effect of esomeprazole on nighttime heartburn and sleep quality in patients with GERD: a randomized, placebo-controlled trial.
Johnson DA; Orr WC; Crawley JA; Traxler B; McCullough J; Brown KA; Roth T
Am J Gastroenterol; 2005 Sep; 100(9):1914-22. PubMed ID: 16128933
[TBL] [Abstract][Full Text] [Related]
7. Responsiveness of measures of heartburn improvement in non-erosive reflux disease.
Junghard O; Halling K
Health Qual Life Outcomes; 2007 Jun; 5():32. PubMed ID: 17562006
[TBL] [Abstract][Full Text] [Related]
8. Onset of relief of symptoms of gastroesophageal reflux disease: post hoc analysis of two previously published studies comparing pantoprazole 20 mg once daily with nizatidine or ranitidine 150 mg twice daily.
Haag S; Holtmann G
Clin Ther; 2010 Apr; 32(4):678-90. PubMed ID: 20435237
[TBL] [Abstract][Full Text] [Related]
9. Quality of life in patients with endoscopy-negative heartburn: reliability and sensitivity of disease-specific instruments.
Talley NJ; Fullerton S; Junghard O; Wiklund I
Am J Gastroenterol; 2001 Jul; 96(7):1998-2004. PubMed ID: 11467624
[TBL] [Abstract][Full Text] [Related]
10. Health-related quality of life improves with treatment-related GERD symptom resolution after adjusting for baseline severity.
Revicki DA; Zodet MW; Joshua-Gotlib S; Levine D; Crawley JA
Health Qual Life Outcomes; 2003 Nov; 1():73. PubMed ID: 14641914
[TBL] [Abstract][Full Text] [Related]
11. Heartburn severity does not predict disease severity in patients with erosive esophagitis.
Fennerty MB; Johnson DA
MedGenMed; 2006 Apr; 8(2):6. PubMed ID: 16926745
[TBL] [Abstract][Full Text] [Related]
12. Clinical trial: the treatment of gastro-oesophageal reflux disease in primary care--prospective randomized comparison of rabeprazole 20 mg with esomeprazole 20 and 40 mg.
Eggleston A; Katelaris PH; Nandurkar S; Thorpe P; Holtmann G;
Aliment Pharmacol Ther; 2009 May; 29(9):967-78. PubMed ID: 19210493
[TBL] [Abstract][Full Text] [Related]
13. The role of acid suppression in patients with endoscopy-negative reflux disease: the effect of treatment with esomeprazole or omeprazole.
Armstrong D; Talley NJ; Lauritsen K; Moum B; Lind T; Tunturi-Hihnala H; Venables T; Green J; Bigard MA; Mössner J; Junghard O
Aliment Pharmacol Ther; 2004 Aug; 20(4):413-21. PubMed ID: 15298635
[TBL] [Abstract][Full Text] [Related]
14. Partial symptom-response to proton pump inhibitors in patients with non-erosive reflux disease or reflux oesophagitis - a post hoc analysis of 5796 patients.
Bytzer P; van Zanten SV; Mattsson H; Wernersson B
Aliment Pharmacol Ther; 2012 Oct; 36(7):635-43. PubMed ID: 22860764
[TBL] [Abstract][Full Text] [Related]
15. Concomitant symptoms itemized in the Reflux Disease Questionnaire are associated with attenuated heartburn response to acid suppression.
Kahrilas PJ; Jonsson A; Denison H; Wernersson B; Hughes N; Howden CW
Am J Gastroenterol; 2012 Sep; 107(9):1354-60. PubMed ID: 22777339
[TBL] [Abstract][Full Text] [Related]
16. Regurgitation is less responsive to acid suppression than heartburn in patients with gastroesophageal reflux disease.
Kahrilas PJ; Jonsson A; Denison H; Wernersson B; Hughes N; Howden CW
Clin Gastroenterol Hepatol; 2012 Jun; 10(6):612-9. PubMed ID: 22343515
[TBL] [Abstract][Full Text] [Related]
17. Clinical trial: esomeprazole for moderate-to-severe nighttime heartburn and gastro-oesophageal reflux disease-related sleep disturbances.
Johnson D; Crawley JA; Hwang C; Brown K
Aliment Pharmacol Ther; 2010 Jul; 32(2):182-90. PubMed ID: 20456306
[TBL] [Abstract][Full Text] [Related]
18. Health-related quality of life outcomes of omeprazole versus ranitidine in poorly responsive symptomatic gastroesophageal reflux disease.
Revicki DA; Sorensen S; Maton PN; Orlando RC
Dig Dis; 1998; 16(5):284-91. PubMed ID: 9892788
[TBL] [Abstract][Full Text] [Related]
19. Predictors of heartburn resolution and erosive esophagitis in patients with GERD.
Orlando RC; Monyak JT; Silberg DG
Curr Med Res Opin; 2009 Sep; 25(9):2091-102. PubMed ID: 19601705
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of esomeprazole for resolution of symptoms of heartburn and acid regurgitation in continuous users of non-steroidal anti-inflammatory drugs.
Hawkey CJ; Jones RH; Yeomans ND; Scheiman JM; Talley NJ; Goldstein JL; Ahlbom H; Naesdal J
Aliment Pharmacol Ther; 2007 Apr; 25(7):813-21. PubMed ID: 17373920
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
